Clinical Trial Update: Hypoalbuminemia in Burn Patients [Phase 4]

View source ↗

Summary

A Phase 4 burn study focusing on hypoalbuminemia in patients with second or third-degree burns has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Second or Third-degree Burns

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Second or Third Degree Burns | Phase 4 | Status: WITHDRAWN